Amelioration of stress in chemical dependency detoxification by transcranial electrostimulation
Identifieur interne : 001971 ( Istex/Corpus ); précédent : 001970; suivant : 001972Amelioration of stress in chemical dependency detoxification by transcranial electrostimulation
Auteurs : Meg Patterson ; Evgeny Krupitsky ; Noel Flood ; Denise Baker ; Lorne PattersonSource :
- Stress Medicine [ 0748-8386 ] ; 1994-04.
English descriptors
- KwdEn :
Abstract
Stress — in the form of the psychic distress and aggression traditionally experienced as a substantial part of the withdrawal syndrome — is a major obstacle to the successful detoxification and rehabilitation of the chemical dependant. Transcranial electrostimulation, a detoxification modality applied for a maximum of 10 days, and ‘cranial electrostimulation’ (known as CES), a treatment adjunct, significantly ameliorate these affective components resulting in a lowered drop‐out rate and enhancing the patient's ability to benefit from relapse‐prevention modalities. Electrostimulation has been demonstrated as efficacious in both inpatient and outpatient settings; and, used appropriately, has no unwanted side‐effects. The work of the authors in relevant animal and clinical studies over the past 20 years is summarized in the light of general electrostimulation research, and their recent clinical investigations described. Various representative psychological assessments are reported. The confusion and controversy arising from the embryonic nature of the electrical criteria integral to electrostimulation applications is considered to be the greatest single obstacle to controlled and replicable research.
Url:
DOI: 10.1002/smi.2460100208
Links to Exploration step
ISTEX:139CC1C3136E3D14636B411C37CD949CF2964ADELe document en format XML
<record><TEI wicri:istexFullTextTei="biblStruct"><teiHeader><fileDesc><titleStmt><title xml:lang="en">Amelioration of stress in chemical dependency detoxification by transcranial electrostimulation</title><author><name sortKey="Patterson, Meg" sort="Patterson, Meg" uniqKey="Patterson M" first="Meg" last="Patterson">Meg Patterson</name><affiliation><mods:affiliation>Visiting Scientist, Dept of Psychiatry, University of Pennsylvania, USA</mods:affiliation></affiliation><affiliation><mods:affiliation>3, Gates Avenue, Roseland, NJ 07068‐1301, USA</mods:affiliation></affiliation></author><author><name sortKey="Krupitsky, Evgeny" sort="Krupitsky, Evgeny" uniqKey="Krupitsky E" first="Evgeny" last="Krupitsky">Evgeny Krupitsky</name><affiliation><mods:affiliation>Research Laboratory, St Petersburg Regional Dispensary of Narcology, Russia</mods:affiliation></affiliation></author><author><name sortKey="Flood, Noel" sort="Flood, Noel" uniqKey="Flood N" first="Noel" last="Flood">Noel Flood</name><affiliation><mods:affiliation>Dept of Psychiatry, Division of Alcohol and Substance Abuse, New York University School of Medicine, USA</mods:affiliation></affiliation></author><author><name sortKey="Baker, Denise" sort="Baker, Denise" uniqKey="Baker D" first="Denise" last="Baker">Denise Baker</name><affiliation><mods:affiliation>Addicare Group of Texas, USA</mods:affiliation></affiliation></author><author><name sortKey="Patterson, Lorne" sort="Patterson, Lorne" uniqKey="Patterson L" first="Lorne" last="Patterson">Lorne Patterson</name><affiliation><mods:affiliation>Churchill Clinic, London, UK</mods:affiliation></affiliation></author></titleStmt><publicationStmt><idno type="wicri:source">ISTEX</idno><idno type="RBID">ISTEX:139CC1C3136E3D14636B411C37CD949CF2964ADE</idno><date when="1994" year="1994">1994</date><idno type="doi">10.1002/smi.2460100208</idno><idno type="url">https://api.istex.fr/document/139CC1C3136E3D14636B411C37CD949CF2964ADE/fulltext/pdf</idno><idno type="wicri:Area/Istex/Corpus">001971</idno><idno type="wicri:explorRef" wicri:stream="Istex" wicri:step="Corpus" wicri:corpus="ISTEX">001971</idno></publicationStmt><sourceDesc><biblStruct><analytic><title level="a" type="main" xml:lang="en">Amelioration of stress in chemical dependency detoxification by transcranial electrostimulation</title><author><name sortKey="Patterson, Meg" sort="Patterson, Meg" uniqKey="Patterson M" first="Meg" last="Patterson">Meg Patterson</name><affiliation><mods:affiliation>Visiting Scientist, Dept of Psychiatry, University of Pennsylvania, USA</mods:affiliation></affiliation><affiliation><mods:affiliation>3, Gates Avenue, Roseland, NJ 07068‐1301, USA</mods:affiliation></affiliation></author><author><name sortKey="Krupitsky, Evgeny" sort="Krupitsky, Evgeny" uniqKey="Krupitsky E" first="Evgeny" last="Krupitsky">Evgeny Krupitsky</name><affiliation><mods:affiliation>Research Laboratory, St Petersburg Regional Dispensary of Narcology, Russia</mods:affiliation></affiliation></author><author><name sortKey="Flood, Noel" sort="Flood, Noel" uniqKey="Flood N" first="Noel" last="Flood">Noel Flood</name><affiliation><mods:affiliation>Dept of Psychiatry, Division of Alcohol and Substance Abuse, New York University School of Medicine, USA</mods:affiliation></affiliation></author><author><name sortKey="Baker, Denise" sort="Baker, Denise" uniqKey="Baker D" first="Denise" last="Baker">Denise Baker</name><affiliation><mods:affiliation>Addicare Group of Texas, USA</mods:affiliation></affiliation></author><author><name sortKey="Patterson, Lorne" sort="Patterson, Lorne" uniqKey="Patterson L" first="Lorne" last="Patterson">Lorne Patterson</name><affiliation><mods:affiliation>Churchill Clinic, London, UK</mods:affiliation></affiliation></author></analytic><monogr></monogr><series><title level="j">Stress Medicine</title><title level="j" type="abbrev">Stress Med.</title><idno type="ISSN">0748-8386</idno><idno type="eISSN">1099-1700</idno><imprint><publisher>John Wiley & Sons, Ltd</publisher><pubPlace>London</pubPlace><date type="published" when="1994-04">1994-04</date><biblScope unit="volume">10</biblScope><biblScope unit="issue">2</biblScope><biblScope unit="page" from="115">115</biblScope><biblScope unit="page" to="126">126</biblScope></imprint><idno type="ISSN">0748-8386</idno></series><idno type="istex">139CC1C3136E3D14636B411C37CD949CF2964ADE</idno><idno type="DOI">10.1002/smi.2460100208</idno><idno type="ArticleID">SMI2460100208</idno></biblStruct></sourceDesc><seriesStmt><idno type="ISSN">0748-8386</idno></seriesStmt></fileDesc><profileDesc><textClass><keywords scheme="KwdEn" xml:lang="en"><term>Neuroelectric Therapy (Net)</term><term>Transcranial electrostimulation</term><term>affective disorders</term><term>detoxification</term><term>relapse</term><term>stress</term></keywords></textClass><langUsage><language ident="en">en</language></langUsage></profileDesc></teiHeader><front><div type="abstract" xml:lang="en">Stress — in the form of the psychic distress and aggression traditionally experienced as a substantial part of the withdrawal syndrome — is a major obstacle to the successful detoxification and rehabilitation of the chemical dependant. Transcranial electrostimulation, a detoxification modality applied for a maximum of 10 days, and ‘cranial electrostimulation’ (known as CES), a treatment adjunct, significantly ameliorate these affective components resulting in a lowered drop‐out rate and enhancing the patient's ability to benefit from relapse‐prevention modalities. Electrostimulation has been demonstrated as efficacious in both inpatient and outpatient settings; and, used appropriately, has no unwanted side‐effects. The work of the authors in relevant animal and clinical studies over the past 20 years is summarized in the light of general electrostimulation research, and their recent clinical investigations described. Various representative psychological assessments are reported. The confusion and controversy arising from the embryonic nature of the electrical criteria integral to electrostimulation applications is considered to be the greatest single obstacle to controlled and replicable research.</div></front></TEI><istex><corpusName>wiley</corpusName><author><json:item><name>Meg Patterson MD, MBE, Frcse</name><affiliations><json:string>Visiting Scientist, Dept of Psychiatry, University of Pennsylvania, USA</json:string><json:string>3, Gates Avenue, Roseland, NJ 07068‐1301, USA</json:string></affiliations></json:item><json:item><name>Evgeny Krupitsky MD, PhD</name><affiliations><json:string>Research Laboratory, St Petersburg Regional Dispensary of Narcology, Russia</json:string></affiliations></json:item><json:item><name>Noel Flood Rmn, Cas</name><affiliations><json:string>Dept of Psychiatry, Division of Alcohol and Substance Abuse, New York University School of Medicine, USA</json:string></affiliations></json:item><json:item><name>Denise Baker Cac, Cas, Ci</name><affiliations><json:string>Addicare Group of Texas, USA</json:string></affiliations></json:item><json:item><name>Lorne Patterson RMN</name><affiliations><json:string>Churchill Clinic, London, UK</json:string></affiliations></json:item></author><subject><json:item><lang><json:string>eng</json:string></lang><value>Transcranial electrostimulation</value></json:item><json:item><lang><json:string>eng</json:string></lang><value>Neuroelectric Therapy (Net)</value></json:item><json:item><lang><json:string>eng</json:string></lang><value>detoxification</value></json:item><json:item><lang><json:string>eng</json:string></lang><value>stress</value></json:item><json:item><lang><json:string>eng</json:string></lang><value>affective disorders</value></json:item><json:item><lang><json:string>eng</json:string></lang><value>relapse</value></json:item></subject><articleId><json:string>SMI2460100208</json:string></articleId><language><json:string>eng</json:string></language><originalGenre><json:string>article</json:string></originalGenre><abstract>Stress — in the form of the psychic distress and aggression traditionally experienced as a substantial part of the withdrawal syndrome — is a major obstacle to the successful detoxification and rehabilitation of the chemical dependant. Transcranial electrostimulation, a detoxification modality applied for a maximum of 10 days, and ‘cranial electrostimulation’ (known as CES), a treatment adjunct, significantly ameliorate these affective components resulting in a lowered drop‐out rate and enhancing the patient's ability to benefit from relapse‐prevention modalities. Electrostimulation has been demonstrated as efficacious in both inpatient and outpatient settings; and, used appropriately, has no unwanted side‐effects. The work of the authors in relevant animal and clinical studies over the past 20 years is summarized in the light of general electrostimulation research, and their recent clinical investigations described. Various representative psychological assessments are reported. The confusion and controversy arising from the embryonic nature of the electrical criteria integral to electrostimulation applications is considered to be the greatest single obstacle to controlled and replicable research.</abstract><qualityIndicators><score>6.968</score><pdfVersion>1.3</pdfVersion><pdfPageSize>540 x 720 pts</pdfPageSize><refBibsNative>true</refBibsNative><abstractCharCount>1216</abstractCharCount><pdfWordCount>5727</pdfWordCount><pdfCharCount>36625</pdfCharCount><pdfPageCount>12</pdfPageCount><abstractWordCount>164</abstractWordCount></qualityIndicators><title>Amelioration of stress in chemical dependency detoxification by transcranial electrostimulation</title><genre><json:string>article</json:string></genre><host><volume>10</volume><publisherId><json:string>SMI</json:string></publisherId><pages><total>12</total><last>126</last><first>115</first></pages><issn><json:string>0748-8386</json:string></issn><issue>2</issue><subject><json:item><value>Article</value></json:item></subject><genre><json:string>journal</json:string></genre><language><json:string>unknown</json:string></language><eissn><json:string>1099-1700</json:string></eissn><title>Stress Medicine</title><doi><json:string>10.1002/(ISSN)1099-1700</json:string></doi></host><categories><wos></wos><scienceMetrix><json:string>health sciences</json:string><json:string>clinical medicine</json:string><json:string>psychiatry</json:string></scienceMetrix><inist><json:string>sciences appliquees, technologies et medecines</json:string><json:string>sciences biologiques et medicales</json:string><json:string>sciences medicales</json:string><json:string>endocrinopathies</json:string></inist></categories><publicationDate>1994</publicationDate><copyrightDate>1994</copyrightDate><doi><json:string>10.1002/smi.2460100208</json:string></doi><id>139CC1C3136E3D14636B411C37CD949CF2964ADE</id><score>1</score><fulltext><json:item><extension>pdf</extension><original>true</original><mimetype>application/pdf</mimetype><uri>https://api.istex.fr/document/139CC1C3136E3D14636B411C37CD949CF2964ADE/fulltext/pdf</uri></json:item><json:item><extension>zip</extension><original>false</original><mimetype>application/zip</mimetype><uri>https://api.istex.fr/document/139CC1C3136E3D14636B411C37CD949CF2964ADE/fulltext/zip</uri></json:item><istex:fulltextTEI uri="https://api.istex.fr/document/139CC1C3136E3D14636B411C37CD949CF2964ADE/fulltext/tei"><teiHeader><fileDesc><titleStmt><title level="a" type="main" xml:lang="en">Amelioration of stress in chemical dependency detoxification by transcranial electrostimulation</title></titleStmt><publicationStmt><authority>ISTEX</authority><publisher>John Wiley & Sons, Ltd</publisher><pubPlace>London</pubPlace><availability><p>Copyright © 1994 John Wiley & Sons, Ltd</p></availability><date>1994</date></publicationStmt><notesStmt><note>The Rank Foundation, UK;</note><note>Frontiers of Science Foundation of Oklahoma City, USA;</note><note>British Medical Association</note></notesStmt><sourceDesc><biblStruct type="inbook"><analytic><title level="a" type="main" xml:lang="en">Amelioration of stress in chemical dependency detoxification by transcranial electrostimulation</title><author xml:id="author-1"><persName><forename type="first">Meg</forename><surname>Patterson</surname></persName><roleName type="degree">MD, MBE, Frcse</roleName><affiliation>Visiting Scientist, Dept of Psychiatry, University of Pennsylvania, USA</affiliation><affiliation>3, Gates Avenue, Roseland, NJ 07068‐1301, USA</affiliation></author><author xml:id="author-2"><persName><forename type="first">Evgeny</forename><surname>Krupitsky</surname></persName><roleName type="degree">MD, PhD</roleName><affiliation>Research Laboratory, St Petersburg Regional Dispensary of Narcology, Russia</affiliation></author><author xml:id="author-3"><persName><forename type="first">Noel</forename><surname>Flood</surname></persName><roleName type="degree">Rmn, Cas</roleName><affiliation>Dept of Psychiatry, Division of Alcohol and Substance Abuse, New York University School of Medicine, USA</affiliation></author><author xml:id="author-4"><persName><forename type="first">Denise</forename><surname>Baker</surname></persName><roleName type="degree">Cac, Cas, Ci</roleName><affiliation>Addicare Group of Texas, USA</affiliation></author><author xml:id="author-5"><persName><forename type="first">Lorne</forename><surname>Patterson</surname></persName><roleName type="degree">RMN</roleName><affiliation>Churchill Clinic, London, UK</affiliation></author></analytic><monogr><title level="j">Stress Medicine</title><title level="j" type="abbrev">Stress Med.</title><idno type="pISSN">0748-8386</idno><idno type="eISSN">1099-1700</idno><idno type="DOI">10.1002/(ISSN)1099-1700</idno><imprint><publisher>John Wiley & Sons, Ltd</publisher><pubPlace>London</pubPlace><date type="published" when="1994-04"></date><biblScope unit="volume">10</biblScope><biblScope unit="issue">2</biblScope><biblScope unit="page" from="115">115</biblScope><biblScope unit="page" to="126">126</biblScope></imprint></monogr><idno type="istex">139CC1C3136E3D14636B411C37CD949CF2964ADE</idno><idno type="DOI">10.1002/smi.2460100208</idno><idno type="ArticleID">SMI2460100208</idno></biblStruct></sourceDesc></fileDesc><profileDesc><creation><date>1994</date></creation><langUsage><language ident="en">en</language></langUsage><abstract xml:lang="en"><p>Stress — in the form of the psychic distress and aggression traditionally experienced as a substantial part of the withdrawal syndrome — is a major obstacle to the successful detoxification and rehabilitation of the chemical dependant. Transcranial electrostimulation, a detoxification modality applied for a maximum of 10 days, and ‘cranial electrostimulation’ (known as CES), a treatment adjunct, significantly ameliorate these affective components resulting in a lowered drop‐out rate and enhancing the patient's ability to benefit from relapse‐prevention modalities. Electrostimulation has been demonstrated as efficacious in both inpatient and outpatient settings; and, used appropriately, has no unwanted side‐effects. The work of the authors in relevant animal and clinical studies over the past 20 years is summarized in the light of general electrostimulation research, and their recent clinical investigations described. Various representative psychological assessments are reported. The confusion and controversy arising from the embryonic nature of the electrical criteria integral to electrostimulation applications is considered to be the greatest single obstacle to controlled and replicable research.</p></abstract><textClass xml:lang="en"><keywords scheme="keyword"><list><head>keywords</head><item><term>Transcranial electrostimulation</term></item><item><term>Neuroelectric Therapy (Net)</term></item><item><term>detoxification</term></item><item><term>stress</term></item><item><term>affective disorders</term></item><item><term>relapse</term></item></list></keywords></textClass><textClass><keywords scheme="Journal Subject"><list><head>article-category</head><item><term>Article</term></item></list></keywords></textClass></profileDesc><revisionDesc><change when="1994-04">Published</change></revisionDesc></teiHeader></istex:fulltextTEI><json:item><extension>txt</extension><original>false</original><mimetype>text/plain</mimetype><uri>https://api.istex.fr/document/139CC1C3136E3D14636B411C37CD949CF2964ADE/fulltext/txt</uri></json:item></fulltext><metadata><istex:metadataXml wicri:clean="Wiley, elements deleted: body"><istex:xmlDeclaration>version="1.0" encoding="UTF-8" standalone="yes"</istex:xmlDeclaration><istex:document><component version="2.0" type="serialArticle" xml:lang="en"><header><publicationMeta level="product"><publisherInfo><publisherName>John Wiley & Sons, Ltd</publisherName><publisherLoc>London</publisherLoc></publisherInfo><doi registered="yes">10.1002/(ISSN)1099-1700</doi><issn type="print">0748-8386</issn><issn type="electronic">1099-1700</issn><idGroup><id type="product" value="SMI"></id></idGroup><titleGroup><title type="main" xml:lang="en" sort="STRESS MEDICINE">Stress Medicine</title><title type="short">Stress Med.</title></titleGroup></publicationMeta><publicationMeta level="part" position="20"><doi origin="wiley" registered="yes">10.1002/smi.v10:2</doi><numberingGroup><numbering type="journalVolume" number="10">10</numbering><numbering type="journalIssue">2</numbering></numberingGroup><coverDate startDate="1994-04">April 1994</coverDate></publicationMeta><publicationMeta level="unit" type="article" position="8" status="forIssue"><doi origin="wiley" registered="yes">10.1002/smi.2460100208</doi><idGroup><id type="unit" value="SMI2460100208"></id></idGroup><countGroup><count type="pageTotal" number="12"></count></countGroup><titleGroup><title type="articleCategory">Article</title><title type="tocHeading1">Articles</title></titleGroup><copyright ownership="publisher">Copyright © 1994 John Wiley & Sons, Ltd</copyright><eventGroup><event type="firstOnline" date="2006-02-10"></event><event type="publishedOnlineFinalForm" date="2006-02-10"></event><event type="xmlConverted" agent="Converter:JWSART34_TO_WML3G version:2.3.2 mode:FullText source:HeaderRef result:HeaderRef" date="2010-03-04"></event><event type="xmlConverted" agent="Converter:WILEY_ML3G_TO_WILEY_ML3GV2 version:3.8.8" date="2014-02-08"></event><event type="xmlConverted" agent="Converter:WML3G_To_WML3G version:4.1.7 mode:FullText,remove_FC" date="2014-11-03"></event></eventGroup><numberingGroup><numbering type="pageFirst">115</numbering><numbering type="pageLast">126</numbering></numberingGroup><correspondenceTo>3, Gates Avenue, Roseland, NJ 07068‐1301, USA</correspondenceTo><linkGroup><link type="toTypesetVersion" href="file:SMI.SMI2460100208.pdf"></link></linkGroup></publicationMeta><contentMeta><countGroup><count type="figureTotal" number="3"></count><count type="tableTotal" number="5"></count><count type="referenceTotal" number="44"></count></countGroup><titleGroup><title type="main" xml:lang="en">Amelioration of stress in chemical dependency detoxification by transcranial electrostimulation</title><title type="short" xml:lang="en">STRESS IN DETOX BY ES</title></titleGroup><creators><creator xml:id="au1" creatorRole="author" affiliationRef="#af1" corresponding="yes"><personName><givenNames>Meg</givenNames><familyName>Patterson</familyName><degrees>MD, MBE, Frcse</degrees></personName></creator><creator xml:id="au2" creatorRole="author" affiliationRef="#af2"><personName><givenNames>Evgeny</givenNames><familyName>Krupitsky</familyName><degrees>MD, PhD</degrees></personName></creator><creator xml:id="au3" creatorRole="author" affiliationRef="#af3"><personName><givenNames>Noel</givenNames><familyName>Flood</familyName><degrees>Rmn, Cas</degrees></personName></creator><creator xml:id="au4" creatorRole="author" affiliationRef="#af4"><personName><givenNames>Denise</givenNames><familyName>Baker</familyName><degrees>Cac, Cas, Ci</degrees></personName></creator><creator xml:id="au5" creatorRole="author" affiliationRef="#af5"><personName><givenNames>Lorne</givenNames><familyName>Patterson</familyName><degrees>RMN</degrees></personName></creator></creators><affiliationGroup><affiliation xml:id="af1" countryCode="US" type="organization"><unparsedAffiliation>Visiting Scientist, Dept of Psychiatry, University of Pennsylvania, USA</unparsedAffiliation></affiliation><affiliation xml:id="af2" countryCode="RU" type="organization"><unparsedAffiliation>Research Laboratory, St Petersburg Regional Dispensary of Narcology, Russia</unparsedAffiliation></affiliation><affiliation xml:id="af3" countryCode="US" type="organization"><unparsedAffiliation>Dept of Psychiatry, Division of Alcohol and Substance Abuse, New York University School of Medicine, USA</unparsedAffiliation></affiliation><affiliation xml:id="af4" countryCode="US" type="organization"><unparsedAffiliation>Addicare Group of Texas, USA</unparsedAffiliation></affiliation><affiliation xml:id="af5" countryCode="US" type="organization"><unparsedAffiliation>Churchill Clinic, London, UK</unparsedAffiliation></affiliation></affiliationGroup><keywordGroup xml:lang="en" type="author"><keyword xml:id="kwd1">Transcranial electrostimulation</keyword><keyword xml:id="kwd2">Neuroelectric Therapy (Net)</keyword><keyword xml:id="kwd3">detoxification</keyword><keyword xml:id="kwd4">stress</keyword><keyword xml:id="kwd5">affective disorders</keyword><keyword xml:id="kwd6">relapse</keyword></keywordGroup><fundingInfo><fundingAgency>The Rank Foundation, UK;</fundingAgency></fundingInfo><fundingInfo><fundingAgency>Frontiers of Science Foundation of Oklahoma City, USA;</fundingAgency></fundingInfo><fundingInfo><fundingAgency>British Medical Association</fundingAgency></fundingInfo><abstractGroup><abstract type="main" xml:lang="en"><title type="main">Abstract</title><p>Stress — in the form of the psychic distress and aggression traditionally experienced as a substantial part of the withdrawal syndrome — is a major obstacle to the successful detoxification and rehabilitation of the chemical dependant. Transcranial electrostimulation, a detoxification modality applied for a maximum of 10 days, and ‘cranial electrostimulation’ (known as CES), a treatment adjunct, significantly ameliorate these affective components resulting in a lowered drop‐out rate and enhancing the patient's ability to benefit from relapse‐prevention modalities. Electrostimulation has been demonstrated as efficacious in both inpatient and outpatient settings; and, used appropriately, has no unwanted side‐effects. The work of the authors in relevant animal and clinical studies over the past 20 years is summarized in the light of general electrostimulation research, and their recent clinical investigations described. Various representative psychological assessments are reported. The confusion and controversy arising from the embryonic nature of the electrical criteria integral to electrostimulation applications is considered to be the greatest single obstacle to controlled and replicable research.</p></abstract></abstractGroup></contentMeta></header></component></istex:document></istex:metadataXml><mods version="3.6"><titleInfo lang="en"><title>Amelioration of stress in chemical dependency detoxification by transcranial electrostimulation</title></titleInfo><titleInfo type="abbreviated" lang="en"><title>STRESS IN DETOX BY ES</title></titleInfo><titleInfo type="alternative" contentType="CDATA" lang="en"><title>Amelioration of stress in chemical dependency detoxification by transcranial electrostimulation</title></titleInfo><name type="personal"><namePart type="given">Meg</namePart><namePart type="family">Patterson</namePart><namePart type="termsOfAddress">MD, MBE, Frcse</namePart><affiliation>Visiting Scientist, Dept of Psychiatry, University of Pennsylvania, USA</affiliation><affiliation>3, Gates Avenue, Roseland, NJ 07068‐1301, USA</affiliation><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">Evgeny</namePart><namePart type="family">Krupitsky</namePart><namePart type="termsOfAddress">MD, PhD</namePart><affiliation>Research Laboratory, St Petersburg Regional Dispensary of Narcology, Russia</affiliation><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">Noel</namePart><namePart type="family">Flood</namePart><namePart type="termsOfAddress">Rmn, Cas</namePart><affiliation>Dept of Psychiatry, Division of Alcohol and Substance Abuse, New York University School of Medicine, USA</affiliation><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">Denise</namePart><namePart type="family">Baker</namePart><namePart type="termsOfAddress">Cac, Cas, Ci</namePart><affiliation>Addicare Group of Texas, USA</affiliation><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">Lorne</namePart><namePart type="family">Patterson</namePart><namePart type="termsOfAddress">RMN</namePart><affiliation>Churchill Clinic, London, UK</affiliation><role><roleTerm type="text">author</roleTerm></role></name><typeOfResource>text</typeOfResource><genre type="article" displayLabel="article"></genre><originInfo><publisher>John Wiley & Sons, Ltd</publisher><place><placeTerm type="text">London</placeTerm></place><dateIssued encoding="w3cdtf">1994-04</dateIssued><copyrightDate encoding="w3cdtf">1994</copyrightDate></originInfo><language><languageTerm type="code" authority="rfc3066">en</languageTerm><languageTerm type="code" authority="iso639-2b">eng</languageTerm></language><physicalDescription><internetMediaType>text/html</internetMediaType><extent unit="figures">3</extent><extent unit="tables">5</extent><extent unit="references">44</extent></physicalDescription><abstract lang="en">Stress — in the form of the psychic distress and aggression traditionally experienced as a substantial part of the withdrawal syndrome — is a major obstacle to the successful detoxification and rehabilitation of the chemical dependant. Transcranial electrostimulation, a detoxification modality applied for a maximum of 10 days, and ‘cranial electrostimulation’ (known as CES), a treatment adjunct, significantly ameliorate these affective components resulting in a lowered drop‐out rate and enhancing the patient's ability to benefit from relapse‐prevention modalities. Electrostimulation has been demonstrated as efficacious in both inpatient and outpatient settings; and, used appropriately, has no unwanted side‐effects. The work of the authors in relevant animal and clinical studies over the past 20 years is summarized in the light of general electrostimulation research, and their recent clinical investigations described. Various representative psychological assessments are reported. The confusion and controversy arising from the embryonic nature of the electrical criteria integral to electrostimulation applications is considered to be the greatest single obstacle to controlled and replicable research.</abstract><note type="funding">The Rank Foundation, UK;</note><note type="funding">Frontiers of Science Foundation of Oklahoma City, USA;</note><note type="funding">British Medical Association</note><subject lang="en"><genre>keywords</genre><topic>Transcranial electrostimulation</topic><topic>Neuroelectric Therapy (Net)</topic><topic>detoxification</topic><topic>stress</topic><topic>affective disorders</topic><topic>relapse</topic></subject><relatedItem type="host"><titleInfo><title>Stress Medicine</title></titleInfo><titleInfo type="abbreviated"><title>Stress Med.</title></titleInfo><genre type="journal">journal</genre><subject><genre>article-category</genre><topic>Article</topic></subject><identifier type="ISSN">0748-8386</identifier><identifier type="eISSN">1099-1700</identifier><identifier type="DOI">10.1002/(ISSN)1099-1700</identifier><identifier type="PublisherID">SMI</identifier><part><date>1994</date><detail type="volume"><caption>vol.</caption><number>10</number></detail><detail type="issue"><caption>no.</caption><number>2</number></detail><extent unit="pages"><start>115</start><end>126</end><total>12</total></extent></part></relatedItem><identifier type="istex">139CC1C3136E3D14636B411C37CD949CF2964ADE</identifier><identifier type="DOI">10.1002/smi.2460100208</identifier><identifier type="ArticleID">SMI2460100208</identifier><accessCondition type="use and reproduction" contentType="copyright">Copyright © 1994 John Wiley & Sons, Ltd</accessCondition><recordInfo><recordContentSource>WILEY</recordContentSource><recordOrigin>John Wiley & Sons, Ltd</recordOrigin></recordInfo></mods></metadata><serie></serie></istex></record>Pour manipuler ce document sous Unix (Dilib)
EXPLOR_STEP=$WICRI_ROOT/Wicri/Psychologie/explor/TherFamFrancoV1/Data/Istex/Corpus
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 001971 | SxmlIndent | more
Ou
HfdSelect -h $EXPLOR_AREA/Data/Istex/Corpus/biblio.hfd -nk 001971 | SxmlIndent | more
Pour mettre un lien sur cette page dans le réseau Wicri
{{Explor lien
|wiki= Wicri/Psychologie
|area= TherFamFrancoV1
|flux= Istex
|étape= Corpus
|type= RBID
|clé= ISTEX:139CC1C3136E3D14636B411C37CD949CF2964ADE
|texte= Amelioration of stress in chemical dependency detoxification by transcranial electrostimulation
}}
| This area was generated with Dilib version V0.6.29. |  |